CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Double Blind, Randomized, Placebo Controlled, Safety and Efficacy Study of ATNC05 in Patients With Atypical Facial Pain With an Open-Label Extension Phase for Nonresponders

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01920087
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:32.171199+00:00
Published At: 2014-03-13T00:00:00+00:00
Record Updated At: 2014-03-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Atypical Facial Pain", "Persistent Idiopathic Facial Pain", "Atypical Trigeminal Neuralgia", "Neuropathic Orofacial Pain", "Neuropathic Facial Pain"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-03-13"
protocolSection.identificationModule.nctId: "NCT01920087"
protocolSection.identificationModule.officialTitle: "Phase II Double Blind, Randomized, Placebo Controlled, Safety and Efficacy Study of ATNC05 in Patients With Atypical Facial Pain With an Open-Label Extension Phase for Nonresponders"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.